A strategic move or a ploy to arrest further shareholder wealth erosion?
08/07/24 -"The Grifols family and Brookfield have agreed to take Grifols private and should submit the bid in the coming weeks. This comes at an opportune time for the controlling shareholders since the shares ..."
Pages
47
Language
English
Published on
08/07/24
You may also be interested by these reports :
29/01/26
The 2025 performance delivered on the management’s guidance, backed by a strong showing from the cornerstone immunology medicine Dupixent, newly ...
29/01/26
Roche finished the year on a strong note, backed by healthy performances across key focus areas. Even the 2026 guidance was encouraging. The ...
28/01/26
Lonza’s full-year 2025 CDMO performance surpassed management’s guidance. Top-line growth was driven by strong double-digit increases in Integrated ...
28/01/26
2025 was a year of US tariff threats and drug pricing pressure on the pharma industry, and for AstraZeneca (REDUCE; UK), it started under the cloud ...